Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Arzneimittel-Forschung

• Publication date

  1997-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 9342423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent

  1995cited by this paper
• Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs

  1994cited by this paper
• Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs.

  1992cited by this paper
• Antifungal activity of the new agent latoconazole in two tinea models.

  1991cited by this paper
• Retention time and concentration in human skin of bifonazole and clotrimazole.

  1984cited by this paper
• Keratinolytic proteinase produced by Candida albicans.

  1984cited by this paper
• Antifungal activity of four antifungal drugs in the cutaneous retention time test.

  1984cited by this paper
• Antimycotic efficacy of bifonazole in vitro and in vivo.

  1983cited by this paper
• Pharmacokinetic studies following systemic and topical administration of [14C]bifonazole in man.

  1983cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Pharmacokinetics of lanoconazole in human skin after repeated topical application

  2022cites this paper
• Efficiency of newly prepared thiazole derivatives against some cutaneous fungi.

  2018cites this paper
• Efficacy of some synthesized thiazoles against dermatophytes.

  2013cites this paper
• Evaluation of combined deactivators-supplemented agar medium (CDSAM) for recovery of dermatophytes from patients with tinea pedis.

  2007cites this paper
• Evaluation of the anti-Trichophyton activity of a prodigiosin analogue produced by γ-proteobacterium, using stratum corneum epidermis of the Yucatan micropig

  2005cites this paper
• Six Novel Antimycotics

  2002cites this paper
• Therapeutic Efficacy of Topically Applied KP-103 against Experimental Tinea Unguium in Guinea Pigs in Comparison with Amorolfine and Terbinafine

  2002cites this paper
• In Vivo Fungicidal Effect of KP‐103 in a Guinea Pig Model of Interdigital Tinea Pedis Determined by Using a New Method for Removing the Antimycotic Carryover Effect

  2002cites this paper
• Therapeutic Efficacy of Topically Applied KP-103 against Experimental Tinea Unguium in Guinea Pigs in Comparison with Amorolfine and Terbinafine

  2002cites this paper
• A Novel Method Using Micropig Stratum Corneum In Vitro for the Evaluation of Anti‐Trichophyton mentagrophytes Activity

  2002cites this paper
• Development of a New Medium Useful for the Recovery of Dermatophytes from Clinical Specimens by Minimizing the Carryover Effect of Antifungal Agents

  2002cites this paper
• In Vitro Antifungal Activity of KP-103, a Novel Triazole Derivative, and Its Therapeutic Efficacy against Experimental Plantar Tinea Pedis and Cutaneous Candidiasis in Guinea Pigs

  2001cites this paper
• [Suppressive effects of lanoconazole on arthus phenomenon in vivo and on production and functions of TNF in vitro].

  2000cites this paper